
After declaring aducanumab a failure, the manufacturer now says the drug may help slow cognitive decline in certain patients. Some experts are skeptical.
By BY GINA KOLATA from NYT Health https://ift.tt/2MZm4JG
via IFTTT
Alzheimer's Disease, Drugs (Pharmaceuticals), Dementia
Source New York Times
Làm đẹp Blog 247
Không có nhận xét nào:
Đăng nhận xét